This stock is a must for Xmas buy list

Profit after taxation surged 455 percent to $21.5 million for the second quarter to September from a loss of $6 million in 2020 at Medical Disposables. For the year to date, profit after tax spiked 458 percent to $47 million, up from a loss of $13 million in 2020.
Income from sales jumped 49 percent to $936 million for the September quarter, up from $630 million in 2020 and climbed 42 percent for the six months ended September 2021 to $1.62 billion, from $1.14 billion in the prior year.
The increase in sales in the second quarter “is due to increased business activity as well as the consolidation of the operations of the new subsidiary Cornwall Enterprises Limited. There has been a significant improvement in the movement of pharmaceutical and medical disposable items, especially with fewer lock-down periods when compared to last year,” Kurt Boothe, Chief Executive Officer, reported to shareholders in the report accompanying the financials.
Gross profit after selling and distribution expenses jumped 74 percent in the quarter to $184 million, up from $106 million in 2020 and climbed 85 percent for the half year to $303 million from $164 million in the prior year. The period’s gross profit percentage rose to 25 percent compared to 23 percent in 2020 for the six months and from 24 percent in 2020 to 25 percent for the September quarter.
Finance and other income added $8 million to profit in the September 2021 quarter versus $1.5 million in 2020 and for the half year $10 million versus $3 million in 2020.
Selling and promotional expenses increased 26 percent from $46 million in the 2020 second quarter to $59 million and rose 14 percent from $103 million in 2020 to $117 million for the six month period.

Medical Disposables.

Administrative expenses jumped 80 percent from $63 million in the 2020 second quarter to $112 million and surged 55 percent from $113 million in 2020 to $175 million for the six months. Depreciation charge moved 90 percent from $7 million for the September 2020 quarter to $13 million in 2021 and rose 45 percent for the half year from $14 million to $20 million.
Finance cost fell 26 percent from $38 million to $28 million in the quarter and dipped 9 percent to $45 million $50 million for the half year. Foreign exchange losses amount to $1.75 million in the latest quarter from $4 million in 2020 and $5.4 million for the year to date versus a slight loss of $76,823 in 2020.
Gross cash flow generated $75 million for the six months, but growth in working capital drove it down to a negative $119 million versus negative $190 million in 2020. The cash flow deficit was financed by net loan inflows of $225 million. The company paid a dividend of $18.4 million during the half year. At the end of the quarter, Current assets ended with $1.79 billion, including cash of $95 million, inventories of $944 million and receivables of $745 million. Current Liabilities amounts to $1.24 billion and includes Payables of $741 million and short term loans of $486 million. Net current assets ended the period $549 million. Shareholders’ equity stands at $1.05 million, with long term borrowings at just $284 million.
Earnings per share came out at 8 cents for the quarter and 18 cents for the half year. ICInsider.com forecasts earnings of 70 cents per share for the current year and $1.50 per share for 2023. The stock traded at $5.62 on the Jamaica Stock Exchange Junior Market on Wednesday with a PE ratio of 8 times, current earnings well below the average of 14.5 currently for the Junior Market. The stock gets the coveted ICInsider.com BUY RATED seal.

About IC Insider.com